chrisvoncsefalvay/vaers-outcomes huggingface dataset:
rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy; rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy; rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy; rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy; rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy), VACCINATION SITE RASH (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy), VACCINATION SITE ERYTHEMA (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy), VACCINATION SITE INDURATION (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy) and VACCINATION SITE PRURITUS (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced VACCINATION SITE WARMTH (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy), VACCINATION SITE RASH (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy), VACCINATION SITE ERYTHEMA (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy), VACCINATION SITE INDURATION (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy) and VACCINATION SITE PRURITUS (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy). At the time of the report, VACCINATION SITE WARMTH (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy), VACCINATION SITE RASH (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy), VACCINATION SITE ERYTHEMA (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy), VACCINATION SITE INDURATION (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy) and VACCINATION SITE PRURITUS (rash at the injection site that looks like an infected mosquito bite, red, hard, hot and itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
received vaccines 6/18/20 6/19/20 increased redness, itchy L Thigh 6/20/20 increased redness, Admit To hospital for iv Abx 17 month old male who presented with two days of local redness, swelling, urticaria and warmth of upper right thigh immediately following 15 mo vaccinations on 6/19. Had fever only on the 1st day after vaccines and decreased PO of solids. was otherwise acting at baseline and not ill appearing. CBC and CRP were within normal limits.
Pfizer 3/18/21, 4/8/21. Positive on 2/18/22
Site: Itching at Injection Site-Mild, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: itchy scalp flaky rough skin on elbow legs and stomach after the two vaccines were administered together-Medium, Additional Details: Pt reported after recieving shingles and covid vaccine together a month later in june and july she experience itchly flaky scalp on elbows, legs, and stomach and was diagnosied with psoriasis per dermatologists
Raised, redness on upper inside of left arm about 4-5 inches in diameter.
No adverse event to report. The SHINGRIX was reconstituted with the wrong diluent. It was reconstituted with 0.7ml of Sterile Water from Merck Sharp and Dohme that is used for ZOSTAVAX. Exp Nov 28.2019 lot NO21894.
Minor rash on left arm between wrist and elbow.Rash went away in that area but moved to elbow area, but much smaller area.; This is a spontaneous report from a contactable other health care professional, the patient. A 73-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8727) via an unspecified route of administration in the left arm on 25Mar2021 at 00:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergies from an unknown date. The patient had known allergies to medications, food, or other products which are unspecified. Concomitant medication included LOTS for an unknown indication from an unknown date taken within 2 weeks of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. one day after the vaccination on 26Mar2021 at 00:00, the patient experienced minor rash on left arm between wrist and elbow, rash went away in that area but moved to elbow area, but much smaller area. The patient did not receive any treatment for the events. The clinical outcome of the event rash on left arm between wrist and elbow was resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Warmth and radiation pain to left shoulder and neck. Reported 03/16/2014 at 11:00am. No treatment given.
Syringe broke?  No liquid made it thru the needle.  It ran down my entire arm to my hand.
I did not have an adverse reaction to the vaccine. I tested positive for COVID-19 via a home test on 08/12/2022. I felt like I had a bad cold with congestion, runny nose and coughing. I called my doctor and she put me on PAXLOVID. I took the medication for 4 out of the 5 days but I had a reaction to it with throwing up, diarrhea, loss of muscle control and super tired. I stopped taking it and did not take anything else for my symptoms.
Swelling, redness, itching @ vac site. Within two days swelled to 4.5 inch circle w/2x4 inch blister in center and headache mid day. Post 3 days was swollen to 5x6 inches w/ larger blister.
Lot of arthritic symptoms, painful joints and swelling. Difficulty with mobility, very stiff.
On 01/27/2022 at approximately 06:45pm, patient called the pharmacy to report a side effect she believes is a result from the Janssen J&J Vaccine that was administered in her left deltoid on 12/09/2021. She stated about 10 days after receiving the vaccination she noticed a "butterfly feeling" in the right side of her chest. She reports it feels like a flutter/muscle spasm. She does not have a history of any heart condition (e.g. hypertension, heart murmur, or heart palpitations). She contacted her PCP on 01/26/2022 who scheduled an EKG for her on 02/04/2022 and told her to report the symptoms to the pharmacy. Patient also reports a headache occurring after the vaccination and the day after the vaccine was administered.  *** Update 02/10/2022 09:48am *** I spoke with staff at PCP's office regarding the EKG from 02/04/2022. Staff stated the patient is okay, she only had some palpitations and will be monitored by the office.
This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 11-OCT-2012 11:37, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Patient c/o feeling dizzy, faint and temporal pressure post 10 minutes of 1st vaccination (Moderna/HRSA). Patient has a medical history of hypertension, Gerd and per husband CSF. Allergies: NKDA. Patient stated she did take her blood pressure medication as prescribed @ noc. Patient vitals were monitored. @ 11:25 AM BP 156/39 HR 96 spo2 97% RA. A/OX3. Patient became anxious and Temporal pressure increased. Ambulance called and patient transferred to Hospital.
I started with joint pain in my wrist and shoulders and hips mostly that continued to get worse and worse and lasted for three weeks. In the past I had Lyme disease and feel like my joints are weakened and had the most reaction from the vaccine.
Patient complained of ligh-headness and numbness if lips. No difficulty breathing, no treatment given. patient left pharmacy after 2 hours.
Around 2:45am on 1/25/19, patient began experiencing entire body muscle spasms and shaking, vomiting and diarrhea that has lasted for 6 hours. She has extreme weakness and exhaustion at this time (1:45pm).
local redness, swelling, induration 4x7cm lt arm @ site of inj;
Patient received a dose of Pfizer vaccine.  It was noted that the vaccine 5 day expiration date/time was 5/12/2021 @ 930 am.  Vaccine was administered to patient at 10:06 am on 5/12/2021.  No adverse reactions noted during observation period.  MD  and management team aware.
Severe fatigue and weakness, hypotension with blood pressure 78/58, presented to Hospital emergency room where they originally wanted to blame it on his Parkinson's disease but decided it probably was an adverse vaccine reaction(gee, I wonder if they reported this). Patient was so weak she could not even get out of bed and bear weight on his legs. No fever or chills. No cough. Labs were normal including COVID-19. Felt normal the following day.
Started having issues on the same day.  After 1st shot I thought I was getting the Moderna but was given the Pfizer instead. I started with a mild headache right away and a sore arm. Then at my second shot, I got the headache and really high pulse rate. Normal rate is 70 and it was in the high 90's to 100's.  Sent a message to my doctor telling her about my high pulse rate.  Doctor said to take Tylenol and rest and after a week they both disappeared.
Body aches all over; Chills; Blood pressure that is elevated for him; Muscle pain; Slight fever; Nausea; Just feeling sick; severely ill; This is a spontaneous case from a contactable consumer(patient) reported that. A male patient of an unspecified age received BNT162B2 (BioNTech/Pfizer vaccine solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced body aches all over, chills, blood pressure that is elevated for him, Muscle pain, slight fever, Nausea, just feeling sick and severely ill. The patient underwent lab tests and procedures which included blood pressure measurement: elevated on unspecified date. The event outcome was unknown for all the events.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
In addition to very sore arm at the injection site for 4-5 days, symptoms similar to mononucleosis which I suffered 10 years ago recurred. Chills, fatigue, sore throat, burning mouth and tongue, muscle aches - all of which I had for most of 2008 with mono. I have been free from these symptoms until having the SHINGRIX vaccine.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 12-JUL-2017, the patient was vaccinated with ZOSTAVAX lot # M018593, subcutaneous for prophylaxis. On 12-JUL-2017, 1 day after onset of therapy, the patient experienced expired product administered. On an unknown date, the patient experienced no adverse event. The outcome of expired product administered and no adverse event is unknown.
Chills, fever, vomiting, extremely tired, vaccine site red warm swollen, red rash next to site
Pt was hot and clammy within 5 minutes of vaccination. She was seated with husband and momentarily passed out for about 30 seconds. She came to and was back to her normal self in about 5 minutes we called emergency services and they came and checked her out and she left feeling fine.
Fatigue, body ache, ringing in the ears, sore arm: started several hours after shot, resolved within 48 hours. Swollen lymph node under arm: started approx. 24 hours after shot, resolved within 48 hours.
Information has been received from a health professional concerning a 28 year old female speech language assistant with no illness at the time of the vaccination and a history of cardiac murmur and migraine who on 07 Nov 2006 was vaccinated with first dose of HPV vaccine (lot 653735/0688F) in the right deltoid at approximately 1100 hours. On 08 Nov 2006, the patient called the medical facility and complained of experiencing blurred vision. On 09 Nov 2006, the patient experienced seeing double. The patient was told to go to the emergency room immediately. On 12 Nov 2006, the patient recovered. It was reported that the events required medical/surgical intervention (other important medical Events) (OMIC). No further information is available.
Within 36 hours, extreme dizziness, vomiting, cold sweat. Could not move. Taken by ambulance to hospital. Admitted for three days with severe vertigo.
red dotted rash only on my chest. the rash starts at my jaw line and goes behind my ears, around the front on my neck, then my entire chest in between each best down to bra strap line and stops.
This case was reported by a consumer (patient) during GSK market research and described the occurrence of difficulty breathing in a female patient who received ADVAIR unspecified inhaler device for chronic obstructive pulmonary disease. A physician or other health care professional has not verified this report. Concurrent medical conditions included chronic obstructive pulmonary disease. Co-suspect medication included Albuterol. On an unknown date, the patient started Fluticasone propionate+salmeterol xinafoate and Salbutamol sulphate (unknown), unknown dosing. At an unknown time after starting Fluticasone propionate+salmeterol xinafoate, the patient experienced, "I need some help with my breathing". At the time of reporting, the outcome of the event was unknown. Follow-up information received on 21 October 2013 from a consumer via a market research program. Co-suspect medications included Influenza vaccine unspecified and Pneumonia vaccine (Non-GSK) received in October 2013 and less than a week after vaccination with Influenza vaccine unspecified and Pneumonia vaccine (Non-GSK) in October 2013, the patient experienced injection site movement impairment and didn't sleep. The patient said in a conversation online: "I got my flu shot and pneumonia shot in the same day last week. One in my left arm, the other in my right. Don't know which was which but I do know I could hardly move my right arm. Didn't sleep for 2 nights." Follow-up information was received on 30 December 2013 via consumer who reported "I had no problems with ADVAIR when I got my flu shot". At the time of the report no other information was provided. The consumer declined to provide authorization to contact physician. Follow-up information was received on 04 January 2014 via market research program. The patient developed bronchitis on unknown date in 2013 (sometime around Thanksgiving and Christmas). No further information provided. No further information will be sought since patient had denied permission prior to this report. Follow-up information was received on 28 July 2014 via market research program. The patient reported "my last COPD (chronic obstructive pulmonary disease) check up was scheduled for 13 June of last year (2013)...my other doctors are concerned that my lungs are worsening and are stressing about getting to my Pulmonologist. He is located in the next town (none in my town) and I can't get there". The patient reported she was trying to "coordinate a visit that is so badly needed. I was supposed to have a CT (computed tomography) and MRI (magnetic resonance image) the first part of this month (every three months) for my cancer and that isn't done either so will have to work on that as well." No further information provided. At the time of the report the outcome of exacerbation of COPD and cancer was unknown.
pt recvd vax; devel diarrhea; fever; myalgias 24 hrs after vax; tx clear liquids & immodium;
Pt vaso vageled  following Pfizer vaccine. RN lied pt on table and lifted her legs. Medics brought pt to privacy screen and hooked her up to cardiac monitor. BP=116/78, HR = 70, SP02=98%, RR=20.  Pt provided water and recovered after 30 minutes of monitoring.  Cleared by medical professional to g home with family.
29 yo male developed large red, swollen, warm area of skin to posterior (L) UE extending to proximal forearm (20x19cm) 2 days ago after receiving 7th Anthrax (Booster) vaccination 3 days ago.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 19-FEB-2014, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On an unknown date later in 2014, the patient was treated for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
12/25/2004 Seen in ER for 2 week HX of cough, runny nose, weakness, crying. Not admitted 12/29/04 admitted to medical center diag with Guillain Barr syndrome. Hosp 2 weeks diag with dysphegia, tube fed for 3 months.   12/18/06 Received hospital medical records which indicate patient was hospitalized 12/29/2004-1/12/2005. Final Dx: Guillian Barre Syndrome; LLL atelectasis; swallowing difficulties/aspiration. Records reveal patient experienced gradual worsening of cough, respiratory distress & difficulty feeding over 2 weeks.  Gradual lethargy leading to loss of head control & limb movement. PCP treated for reactive airway diseas on 3 visits & was seen in ER x 1 for stridor secondary to viral syndrome.  Neuro consult done.  Noted to have general hypotonia with grunting respirations.  Treated w/IVIG.  Slow improvement.  PT/OT/feeding consults done with slow improvement.  Remained on NG tube feeds at d/c to home with Home Health nursing.
underarm was in pain; chills; underarm was swollen; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), SWELLING (underarm was swollen) and AXILLARY PAIN (underarm was in pain) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, the patient experienced CHILLS (chills) and SWELLING (underarm was swollen). On an unknown date, the patient experienced AXILLARY PAIN (underarm was in pain). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date for Pain, at an unspecified dose and frequency. At the time of the report, CHILLS (chills), SWELLING (underarm was swollen) and AXILLARY PAIN (underarm was in pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications are provided.   Reporter did not allow further contact
large pericardial effusion with early signs of tamponade physiology; large pericardial effusion with early signs of tamponade physiology; dose 1, 04Mar2021/dose 2, 04Mar2021; dose 1, 04Mar2021/dose 2, 04Mar2021; This is a spontaneous report from a contactable other health care professional. A 58-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 intramuscular, administered in Arm Right on 04Mar2021 (Lot Number: EN6203) as 1ST DOSE, SINGLE, dose 2, administered in Arm Left on 04Mar2021 (Lot Number: EP6955) as 2ND DOSE, SINGLE for covid-19 immunization.  Medical history included Stage IV colorectal adenocarcinoma, Shellfish (rash), Peanuts (rash) and rash. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included cetuximab; acetylsalicylic acid (ASPIRIN); atorvastatin; cholecalciferol; levothyroxine.  The patient experienced large pericardial effusion with early signs of tamponade physiology on 01Apr2021. Malignancy and infection were ruled out by cytology which showed only mesothelial cells; cultures were negative. The adverse event result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Pericardiocentesis treatment received. The patient hospitalized for 6 days. The patient underwent nasal swab COVID test negative on 08May2021. The outcome was recovered.; Sender's Comments: Reported 'large pericardial effusion with early signs of tamponade physiology', occurred 28 days after bnt162b2 vaccination, is considered unrelated to bnt162b2 but more likely an intercurrent medical condition. Patient's underlying malignancy, concurrent medical condition for which levothyroxine was administered, concomitant medication cetuximab may have contributed to reported event.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Janssen COVID-19 Vaccine EUA Immediate severe pain during injection, within a few minutes it was down my arm into my hand and also up into my neck.   General feeling of exhaustion set in a few hours later and lasted a day.  Also during the night I had severe cramps in the leg on that right side (the side I had the injection on).  The cramps kept coming all night long all through the right foot and leg.  Foot, ankle , upper and lower leg and knee cramps.  The cramps were severe.
Right upper arm with induration 2cmx3cm and erythema 2cmx2cm. ? tender to touch
Fever of 101 started 1 1/2 hr after injection and lasted approx 48 hrs.  Red generalized raised body rash appeared approx 48 hrs after injection, hives on back. Motrin was given day of injection.  Liquid Benadryl 48 hrs after injection, 3 day rx of oral prednisone.
I have had a headache since the evening of the injection.  I also have a lump in my muscle at the injection site, and my arm itches.